25
Views
5
CrossRef citations to date
0
Altmetric
Original

Long-term follow-up of people with co-existing psychiatric and substance use disorders: patterns of use and outcomes

, , , , &
Pages 249-258 | Received 05 Nov 2004, Accepted 03 Aug 2005, Published online: 26 Aug 2009

References

  • Mueser K T, Bennett M, Kushner M G. Epidemiology of substance use disorders among persons with chronic mental illness. Double jeopardy: chronic mental illness and substance use disorders, A F Lehman, L B Dixon. Harwood Academic, ChurSwitzerland 1995; 9–25
  • Teesson M, Hall W, Lynskey M, Degenhardt L. Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing. Aust NZ J Psychiatry 2000; 34: 206–213
  • Weaver T, Hickman M, Rutter D, Ward J, Stimson G, Renton A. The prevalence and management of co-morbid substance misuse and mental illness: results of a screening survey in substance misuse and mental health treatment populations. Drug Alcohol Rev 2001; 20: 407–416
  • Johnson M E, Brems C, Burke S. Recognizing comorbidity among drug users in treatment. Am J Drug Alcohol Abuse 2002; 28: 243–261
  • Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Aust NZ J Psychiatry 2000; 34: 221–236
  • Teesson M, Burns L. National Comorbidity Project. Commonwealth Department of Health and Aged Care, Canberra 2001
  • Drake R, Brunette M. Complications of severe mental illness related to alcohol and drug use disorders. Recent developments in alcoholism, The consequences of alcoholism: medical neuropsychiatric economic cross-cultural, M Galanter. Plenum Press, New York 1998; vol 14: 285–299
  • Drake R E, McLaughlin P, Pepper B, Minkoff K. Dual diagnosis of major mental illness and substance disorder: an overview. New Dir Youth Dev 1991; 50: 3–12
  • Carey M P, Carey K B, Meisler A W. Psychiatric symptoms in mentally ill chemical abusers. J Nerv Ment Dis 1991; 179: 136–138
  • Brady K T, Anton R F, Ballenger J C, Lydiard R, Adinoff B, Selander J. Cocaine abuse among schizophrenic patients: 143rd Annual Meeting of the American Psychiatric Association. Am J Psychiatry 1990; 147: 1164–1167
  • Cuffel B J, Chase P. Remission and relapse of substance use disorders in schizophrenia. J Nerv Ment Dis 1994; 182: 342–348
  • Bartels S J, Drake R E, Wallach M A. Long-term course of substance use disorders among patients with severe mental illness. Psychiatr Serv 1995; 46: 248–251
  • Baker A, Lewin T, Reichler H. Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatr Scand 2002; 106: 233–240
  • Baker A, Lewin T, Reichler H, et al. Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction 2002; 97: 1329–1337
  • Marlatt G A, Gordon J R. Relapse prevention: maintenance strategies in the treatment of addictive behaviours. Guilford Press, New York 1985
  • Siegal H A, Li L, Rapp R C. Abstinence trajectories among treated crack cocaine users. Addict Behav 2002; 27: 437–449
  • Spitzer R L, Williams J BW, Gibbon M, First M B. Structured Clinical Interview for DSM-III-R—patient edition (SCID-P). American Psychiatric Press, Washington, DC 1990
  • Darke S, Ward J, Hall W, Heather N, Wodak A. The Opiate Treatment Index (OTI) researcher's manual. National Drug and Alcohol Research Centre, Sydney 1991, Technical report no. 11
  • Pols R G, Hawks D V. Is there a safe level of daily consumption of alcohol for men and women?. Australian Government Publishing Service, Canberra 1992
  • Derogatis L R, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13: 595–605
  • Beck A T, Steer R A, Brown G K. Beck Depression Inventory—II. Psychological Corporation, San Antonio, TX 1996
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders 4th edn (DSM-IV). American Psychiatric Association, Washington 1994
  • Deering D EA, Sellman J D. An inter-rater reliability study of the Opiate Treatment Index. Drug Alcohol Rev 1996; 15: 57–63
  • Reichler H, Baker A, Lewin T, Carr V. Smoking among in-patients with drug related problems in an Australian psychiatric hospital. Drug Alcohol Rev 2001; 20: 231–237
  • Cantor-Graae E, Nordstrom T F, McNeil T. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 2001; 48: 69–82
  • Fowler I L, Carr V J, Carter N T, Lewin T J. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24: 443–455
  • DeQuardo J R, Carpenter C F, Tandon R. Patterns of substance abuse in schizophrenia: nature and significance. J Psychiatr Res 1994; 28: 267–275
  • Virgo N, Bennett G, Higgins D, Bennett L, Thomas P. The prevalence and characteristics of co-occurring serious mental illness (SMI) and substance abuse or dependence in the patients of adult mental health and addictions services in eastern Dorset. J Ment Health 2001; 10: 175–188
  • Orford J. Excessive appetites: a psychological view of addictions, 2nd edn. Wiley, Chichester 2001
  • Sobell L C, Cunningham J A, Sobell M B. Recovery from alcohol problems with and without treatment: prevalence in two population surveys. Am J Public Health 1996; 86: 966–972
  • Drake R E, Wallach M A. Substance abuse among the chronic mentally ill. Hosp Commun Psychiatry 1989; 40: 1041–1046
  • Primm A B, Gomez M P, Tzolova-Iontchev I, Perry W, Crum R M. Chronically mentally ill patients with and without substance use disorders: a pilot study. J Psychiatr Res 2000; 95: 261–270
  • Australian Bureau of Statistics. Deaths, Australia 3302.0. Australian Bureau of Statistics. 2001, Available at: http//:www.abs.gov.au/AUSSTATS
  • Lawrence D, Jablensky A V, Holman C DJ, Pinder T J. Mortality in Western Australian psychiatric patients. Psychiatry Psychiatr Epidemiol 2000; 35: 341–347
  • Miller W R, Leckman A L, Delaney H D, Tinkcom M. Long-term follow-up of behavioral self-control training. J Stud Alcohol 1992; 53: 249–261

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.